about
Intravenous nitrates for pharmacological stimulation during head-up tilt testing in patients with suspected vasovagal syncope and healthy controls.Syncope in children and adolescents of Hong Kong.Autonomic syncope in pediatrics: a practice-oriented approach to classification, pathophysiology, diagnosis, and management.The prevalence of common cardiovascular diseases among 17-year-old Israeli conscripts.Age of first faint in patients with vasovagal syncope.Vasovagal syncope in medical students and their first-degree relatives.Usefulness of ocular compression during electroencephalography in distinguishing breath-holding spells and syncope from epileptic seizures.Lifetime cumulative incidence of syncope in the general population: a study of 549 Dutch subjects aged 35-60 years.Use of the implantable loop recorder in children and adolescents.Worsening of symptoms before presentation with vasovagal syncope.Aetiologic and clinical characteristics of syncope in Chinese children.How revealing are insertable loop recorders in pediatrics?Hair-grooming syncope in children.The prevalence and cost of the faint and fall problem in the state of Utah.Head-up tilt testing in children and young people: a retrospective observational study.Clinical categorization of childhood syncope.[From loss of consciousness to syncope].Comparison of corrected QT interval as measured on electroencephalography versus 12-lead electrocardiography in children with a history of syncope.Exercise-induced intraventricular obstruction in a child with near syncope and chest pain during exercise.The effect of paediatric syncope on health-related quality of life.Value of history taking in children and adolescents with cardiac syncope.Patterns and preexisting risk factors of 30-day mortality after a primary discharge diagnosis of syncope or near syncope.Diagnostic value of serum brain natriuretic peptide in syncope in children and adolescents.Practice variation and resource use in the evaluation of pediatric vasovagal syncope: are pediatric cardiologists over-testing?Cerebral blood flow of children with vasovagal syncope.Oral rehydration salts: an effective choice for the treatment of children with vasovagal syncope.Risk of cardiac disease and observations on lack of potential predictors by clinical history among children presenting for cardiac evaluation of mid-exertional syncope.Current approaches to the clinical assessment of syncope in pediatric population.Recovery position significantly associated with a reduced admission rate of children with loss of consciousness.Syncope: Not for the faint hearted.Tilt table testing to diagnose pseudosyncope in the pediatric population.Syncope and Epilepsy coexist in 'possible' and 'drug-resistant' epilepsy (Overlap between Epilepsy and Syncope Study - OESYS)Cost of Unnecessary Testing in the Evaluation of Pediatric Syncope.Diagnostic and Therapeutic Management of a First Unprovoked Seizure in Children and Adolescents With a Focus on the Revised Diagnostic Criteria for Epilepsy.Syncope in Pediatric Practice.
P2860
Q33145174-1DEB1CF1-DB85-4E9A-BC61-C730E8666110Q33147732-0F1D33F2-2D51-48A3-AB4A-4B38DAE726EEQ33151116-E64AD05D-60A5-48FB-8E56-DF926BDE0B01Q33152777-EAA853E1-35E6-4A2B-AE65-1E15AB61A1D2Q33153503-7DE9B943-1961-4B8A-BCA3-197FD407B23DQ33154054-001E9686-202B-4D6E-945C-DB3665738211Q33154308-890D5823-1067-4E3F-BE9C-152E4A745BFDQ33154430-239DD685-1BF6-4DD9-8B77-AFC6B13D5BE1Q33154492-DE28F382-B5D9-4F81-B60B-F03413DDE731Q33155387-F32852D3-2068-4514-901A-DDDA3C72E0CBQ33155453-2E6D893D-7504-4446-BADF-D51E37C8B3BBQ33156019-81FA9705-BFEF-4353-9A0F-6F252388AF5FQ33157558-1434F370-3CC7-4E3B-B39F-33F7D3AE93B3Q33159383-D877D291-1B23-46F3-B083-D8D794470420Q33159633-D1EB300C-EB78-4B2D-B284-316F917743AAQ33159874-D2CDB4E6-A956-42E4-BF6E-E7409B48A93FQ33159965-407A5097-689D-40F6-B3B2-7138CEBDD3B3Q33160105-89F90B43-F983-4DB2-9EDA-FF48CF186E4DQ33160270-0B3096CF-87CB-42BF-A53B-B6B8044C9D0CQ33160994-D96C4332-802F-4299-A4B2-E0B7F6F4D34EQ33161094-BED92B5B-AB2D-4211-BEFA-0A5B3317DF12Q33161297-29575AAE-493E-4C54-9EB7-B54C84DFD721Q33162324-2CC6009F-9F7F-4075-A493-6BC5FDC6F890Q33163632-A75A3C65-3554-482D-9713-73F3F89ABD30Q33163691-7CB13742-7628-47FA-828E-709BAE6D228CQ33165160-3EDA7837-CA92-44F7-9921-69BD2E432370Q33166126-04EA9C4F-FA3F-463C-A1C4-A3229FFE8F8DQ33166635-4E466609-7575-4CDA-B47F-7E0813E8C15DQ33166729-6DF64B0B-377F-407F-B6E0-1BF674EF2AD0Q33167189-24F36CE5-D96C-427E-865F-803AF7CD2ED2Q33168316-37466B5E-0ABC-48A1-86BF-B01A22CCDBDDQ33168318-1582BB76-E749-4DB7-9F8C-04B548078905Q33168657-BD5542C8-7EF1-41B8-A1DF-B0876164751AQ39306390-6F0B830A-40C3-45FA-A8A3-23AF5C57F9EBQ47222448-34747D73-43ED-4B96-9F56-D973152A865F
P2860
description
im April 1997 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 April 1997
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 1997
@uk
name
Syncope in Children and Adolescents
@en
Syncope in Children and Adolescents
@nl
type
label
Syncope in Children and Adolescents
@en
Syncope in Children and Adolescents
@nl
prefLabel
Syncope in Children and Adolescents
@en
Syncope in Children and Adolescents
@nl
P2093
P1476
Syncope in children and adolescents
@en
P2093
C J Porter
D J Driscoll
P C Wollan
P304
P356
10.1016/S0735-1097(97)00020-X
P407
P577
1997-04-01T00:00:00Z